跳转至内容
Merck
CN
  • BVR-A Deficiency Leads to Autophagy Impairment through the Dysregulation of AMPK/mTOR Axis in the Brain-Implications for Neurodegeneration.

BVR-A Deficiency Leads to Autophagy Impairment through the Dysregulation of AMPK/mTOR Axis in the Brain-Implications for Neurodegeneration.

Antioxidants (Basel, Switzerland) (2020-07-31)
Chiara Lanzillotta, Ilaria Zuliani, Chirag Vasavda, Solomon H Snyder, Bindu D Paul, Marzia Perluigi, Fabio Di Di Domenico, Eugenio Barone
摘要

Biliverdin reductase-A (BVR-A) impairment is associated with increased accumulation of oxidatively-damaged proteins along with the impairment of autophagy in the brain during neurodegenerative disorders. Reduced autophagy inhibits the clearance of misfolded proteins, which then form neurotoxic aggregates promoting neuronal death. The aim of our study was to clarify the role for BVR-A in the regulation of the mTOR/autophagy axis by evaluating age-associated changes (2, 6 and 11 months) in cerebral cortex samples collected from BVR-A knock-out (BVR-A-/-) and wild-type (WT) mice. Our results show that BVR-A deficiency leads to the accumulation of oxidatively-damaged proteins along with mTOR hyper-activation in the cortex. This process starts in juvenile mice and persists with aging. mTOR hyper-activation is associated with the impairment of autophagy as highlighted by reduced levels of Beclin-1, LC3, LC3II/I ratio, Atg5-Atg12 complex and Atg7 in the cortex of BVR-A-/- mice. Furthermore, we have identified the dysregulation of AMP-activated protein kinase (AMPK) as a critical event driving mTOR hyper-activation in the absence of BVR-A. Overall, our results suggest that BVR-A is a new player in the regulation of autophagy, which may be targeted to arrive at novel therapeutics for diseases involving impaired autophagy.

材料
Product Number
品牌
产品描述

Sigma-Aldrich
磷酸酶抑制剂混合物3, DMSO solution
Sigma-Aldrich
抗山羊 IgG(全分子)-过氧化物酶 兔抗, affinity isolated antibody, buffered aqueous solution
Millipore
蛋白酶抑制剂混合物套装II, The Protease Inhibitor Cocktail Set II controls the activity of Protease. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.
Sigma-Aldrich
Anti-Goat IgG (whole molecule)–Alkaline Phosphatase antibody produced in rabbit, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Anti-Mouse IgG (Fab specific)–Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous solution